Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells

Leukemia

Volumn 13, Issue 7, 1999, Pages 1028-1036

  Blagosklonny, M V ^a,b   Chuman, Y ^a   Bergan, R C ^a   Fojo, T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Vascular Medicine Branch   (United States)

Author keywords

Apoptosis; Bcl 2; Leukemia; MAPK; Paclitaxel; Raf 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PACLITAXEL; PHORBOL ESTER; PROTEIN BCL 2; PROTEIN P21; PROTEIN TYROSINE KINASE; RAF PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MICROTUBULE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

EID: 0032776120     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401449     Document Type: Article

References (62)

1. Marshall CJ. Specificity of receptor tyrosine kinase signaling - transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-185.
2. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E, McMahon M. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 1998; 12: 1903-1929.
3. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR. PKC-a activates Raf-1 by direct phosphorylation. Nature 1993; 364: 249-252.
4. Marais R, Light Y, Mason C, Paterson H, Olson MF, Marshall CJ. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 1998; 280: 109-112.
5. McCubrey JA, Steelman LS, Sandlin G, Riddle RS, Ways DK. Effects of phorbol esters on an interleukin-3-dependent cell line. Blood 1990; 76: 63-72.
6. Huberman E. Callaham MF. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci USA 1979; 76: 1293-1297.
7. Rovera G, O'Brien TG, Diamond L. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science 1979; 204: 868-870.
8. Han ZT, Zhu XX, Yang RY, Sun JZ, Tian GF, Liu XJ, Cao GS, Newmark HL, Conney AH, Chang RL. Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity. Proc Natl Acad Sci USA 1998; 95: 5357-5361.
9. Kharbanda S, Saleem A, Emoto Y, Stone R, Rapp U, Kufe D. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J Biol Chem 1994; 269: 872-878.
10. Blagosklonny MV, Giannakakou P, El-Deiry WS, Kingston DGI, Higgs PI, Neckers L, Fojo T. Raf1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 1997; 57: 130-135.
11. Torres K, Horwitz SB. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 1998; 58: 3620-3626.
12. Laird AD, Taylor SJ, Oberst M, Shalloway D. Raf-1 is activated during mitosis. J Biol Chem 1995; 45: 26742-26745.
13. Lovric J, Moelling K. Activation of Mil/Raf protein kinase in mitotic cells. Oncogens 1996; 12: 1109-1116.
14. Ziogas A, Lorenz IC, Moelling K, Radziwill G. Mitotic Raf-1 is stimulated independently of Ras and is active in the cytoplasm. J Biol Chem 1998; 273: 24108-24114.
15. Laird AD, Morrison DK, Shalloway D. Characterization of Raf-1 activation in mitosis. J Biol Chem 1999; 274: 4430-4439.
16. Haldar S, Basu A, Croce CM. Bc12 is the guardian of microtubule integrity. Cancer Res 1997; 57: 229-233.
17. Reed JC. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 1997, 34: 9-19.
18. Poruchynsky MS, Wang EW, Rudin CM, Blagosklonny MV, Fojo T. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Cancer Res 1998; 58: 3331-3338.
19. Zu YL, Ai Y, Gilchrist A, Labadia ME, Shaafi RI, Huang CK. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 1996; 87: 5287-5296.
20. Schultz H, Engel K, Gaestel M. PMA-induced activation of the p42/44ERK- and p38RK-MAP kinase cascades in HL-60 cells in PKC dependent but not essential for differentiation to the macrophage-like phenotype. J Cell Physiol 1997; 173: 310-318.
21. Takenaka K, Moriguchi T, Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998; 280: 599-602.
22. Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, Neckers LM. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-Mitogen-activated protein kinase signaling pathway. Mol Cell Biol 1996; 16: 5839-5845.
23. Crespo P, Xu N, Daniotti JL, Troppmair J, Rapp UR, Gutkind JS. Signaling through transforming G protein-coupled receptors in NIH 3T3 cells involves c-Raf activation. Evidence for a protein kinase C-independent pathway. J Biol Chem 1994; 269: 21103-21109.
24. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 1997; 16: 968-977.
25. Blagosklonny MV, Prabhu NS, El-Deiry WS. Defects in p21WAF1/CIP1, Rb, c-myc signaling in phorbol ester-resistant cancer cells. Cancer Res 1997; 57: 320-325.
26. Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 1995; 92: 4507-4511.
27. Blagosklonny MV, Schulte TW, Nguyen P, Trepel J, Neckers L. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 1996; 56: 1851-1854.
28. Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD, Pietenpol JA. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J Biol Chem 1998; 273: 30777-30784.
29. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316.
30. Bhalla K, Ibrado AM, Tourkina E, Tang C, Maloney ME, Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993; 7: 563-568.
31. Ibrado AM, Kim CN, Bhalla K. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells. Leukemia 1998; 12: 1930-1936.
32. Wartmann M, Hofer P, Turowski P, Saltiel AR, Hynes NE. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J Biol Chem 1997; 272: 3915-3923.
33. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278: 1966-1968.
34. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996; 74: 589-607.
35. Wang T-H, Wang H-S, Ichijo H, Giannakakou P, Foster JS, Fojo T, Wimalasena J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathway. J Biol Chem 1998; 273: 4928-4936.
36. Straus DB, Weiss A. Genetic evidence for the involvement of the Ick tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992; 70: 585-593.
37. + T cells. Science 1996; 271: 1272-1276.
38. Lin K, Abraham KM. Targets of p56lck activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway, Int Immunol 1997; 9: 291-306.
39. An WG, Schnur RC, Neckers LM, Blagosklonny MV. Depletion of ErbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity. Cancer Chemother Pbarmacol 1997; 40: 60-64.
40. Ling Y-H, Tornos C, Perez-Soler R. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J Biol Chem 1998; 273: 18984-18991.
41. Pathan NI, Ashendel CL, Geahlen RL, Harrison ML. Activation of T cell Raf-1 at mitosis requires the protein-tyrosine kinase Lck. J Biol Chem 1996; 271: 30315-30317.
42. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of bcl2 phosphorylation and apoptosis through cyclic AMP dependent protein kinase. Mol Cell Biol 1998; 18: 3509-3517.
43. Donaldson KL, Goolsby G, Kiener PA, Wahl AF. Activation of p34cdc coincident with taxol-induced apoptosis. Cell Growth Diff 1994; 5: 1041-1050.
44. Long BH, Fairchild CR. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 1994; 54: 4355-4361.
45. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exist and apoptotic cell death. Cancer Res 1996; 56: 816-825.
46. Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998; 10: 123-130.
47. Sewing A, Wiseman B, Lloyd AC, Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 1997; 17: 5588-5597.
48. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 1997; 17: 5598-5611.
49. Blagosklonny MV. The mitogen-activated protein kinase pathway mediates growth arrest or E1A-dependent apoptosis in SKBr3 human breast cancer cells, Int J Cancer 1998; 78: 511-517.
50. Ravi RK, McMahon M, Zang YG, Williams JR, Dillehay LE, Nelkin BD, Mabry M. Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells. J Cell Biochem 1999; 72: 458-469.
51. Basu A, Haldar S. Microtubule-damaging drugs triggered Bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of Bcl2 protein, Int J Oncol 1998; 13: 659-664.
52. Hu ZB, Minden MD, McCulloch EA. Phosphorylation of Bcl-2 after exposure of human leukemic cells to retinoic acid. Blood 1998; 92: 1768-1775.
53. Krajewski S, Tanaka S, Takayama MJ, Schibler W, Fenton W, Reed IC. Investigations of the subcellular distribution of the Bcl-2 protein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membrane. Cancer Res 1993; 53: 4701-4714.
54. Reed JC. A day in the life of the Bcl-2 protein: does the turnover rate of Bcl-2 serve as a biological clock for cellular lifespan regulation? Leukemia Res 1996; 20: 109-111.
55. Ross J. A hypothesis to explain why translation inhibitors stabilize mRNAs in mammalian cells: mRNA stability and mitosis. Bio-Essays 1997; 19: 527-529.
56. Horwitz SB, Shen HJ, He L, Dittmar P, Neef R, Chen J, Schubart UK. The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation. J Biol Chem 1997; 272: 8129-8132.
57. Larsson N, Marklund U, Gradin HM, Brattsand C, Gullberg M. Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol 1997; 17: 5530-5539.
58. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 1995; 92: 8881-8885.
59. Ding A, Chen B, Fuortes M, Blum E. Association of mitogen-activated protein kinases with microtubules in mouse macrophages. I Exp Med 1996; 183: 1899-1904.
60. Zhou R, Oskarsson M, Paules RS, Schulz N, Cleveland D, Vande Woude GF. Ability of the c-mos product to associate with and phosphorylate tubulin. Science 1991; 251: 671-678.
61. Sontag E, Nunbhakdi-Craig V, Bloom CS, Mumby MC. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol 1995; 128: 1131-1144.
62. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.